porcin
epidem
diarrhea
ped
viral
infect
caus
oral
infect
ped
viru
pedv
caus
symptom
includ
wateri
diarrhea
anorexia
mortal
rate
ped
high
piglet
wean
pig
may
transient
diarrhea
remain
asymptomat
even
oral
administr
viru
ped
firstli
identifi
earli
japan
nationwid
pandem
also
record
septemb
ped
report
okinawa
prefectur
interv
year
viru
spread
rapidli
nationwid
isol
viral
strain
divid
previous
report
strain
japan
genet
similar
report
us
may
belong
genogroup
accord
phylogenet
analysi
viral
wholegenom
sequenc
also
call
us
prototypelik
strain
subsequ
anoth
genogroup
field
strain
call
indel
insert
delet
spike
gene
strain
also
isol
japan
strain
larger
delet
spike
gene
report
octob
current
sever
genogroup
strain
circul
japanes
pig
farm
anoth
outbreak
countri
vaccin
ideal
control
measur
prevent
infecti
diseas
sinc
intramuscular
live
inactiv
vaccin
introduc
asian
countri
today
oral
vaccin
commerci
south
korea
philippin
vaccin
base
genogroup
strain
differ
recent
global
epidem
strain
pedv
sinc
ped
outbreak
north
america
april
vaccin
base
truncat
pedv
spike
gene
produc
sirravaxsm
rna
particl
technolog
platform
inactiv
whole
viru
vaccin
formul
adjuv
use
us
respect
north
american
vaccin
base
genogroup
strain
million
dose
live
vaccin
produc
genogroup
strain
suppli
japanes
domest
market
although
numer
vaccin
util
pig
farm
ped
outbreak
still
report
vaccin
farm
japan
present
studi
evalu
effect
convent
live
vaccin
base
genogroup
strain
emerg
field
strain
isol
genogroup
field
strain
perform
challeng
test
use
pedv
antibodi
pedv
free
pregnant
sow
addit
compar
mortal
rate
suckl
piglet
among
ped
affect
farm
assess
effect
live
vaccin
field
situat
genogroup
field
strain
isol
vero
cell
cultur
use
inoculum
challeng
test
jejunum
six
piglet
show
wateri
diarrhea
obtain
ped
affect
farm
specimen
use
gener
wv
homogen
eagl
minimum
essenti
medium
mem
life
technolog
homogen
centrifug
min
supernat
filter
pores
filter
viru
isol
pedv
perform
vero
cell
previous
describ
brief
vero
cell
cultur
mem
supplement
heatinactiv
fetal
bovin
serum
tryptos
phosphat
broth
tpb
antibiot
inocul
cultur
medium
remov
monolay
cell
wash
twice
inocul
medium
mem
supplement
tpb
yeast
extract
trypsin
sigma
specimen
inocul
inocul
media
adsorpt
min
inocul
medium
remov
ml
inocul
medium
ad
well
cultur
incub
examin
cytopath
effect
cpe
daili
viru
titrat
perform
plate
serial
dilut
perform
quadrupl
per
dilut
cultur
examin
cpe
daili
viru
titer
determin
accord
reed
muench
method
express
tissu
cultur
infect
dose
ml
viral
rna
extract
viru
cultur
use
trizol
life
technolog
accord
manufactur
instruct
cdna
synthes
viral
rna
use
transcriptor
high
fidel
cdna
synthesi
kit
roch
diagnost
pcr
perform
cdna
use
highfidel
dna
polymeras
finnzym
spike
gene
amplifi
primer
accord
previou
report
nucleotid
sequenc
spike
gene
determin
directli
pcramplifi
product
fasmac
sequenc
servic
spike
gene
sequenc
isol
design
deposit
genbank
access
dna
align
phylogenet
tree
analysi
perform
use
maximumlikelihood
method
clustalw
method
gener
time
revers
nucleotid
substitut
model
bootstrap
test
replic
mega
softwar
potenti
nlink
glycosyl
site
predict
netnglyc
server
three
pregnant
sow
confirm
serolog
neg
pedv
neutral
antibodi
first
vaccin
vaccin
nisseiken
co
ltd
lot
contain
strain
mldose
attenu
vero
cell
cultur
vaccin
strain
belong
genogroup
two
pregnant
sow
vaccin
intramuscularli
week
farrow
vaccin
dose
time
nonvaccin
pregnant
sow
serv
neg
control
serum
sampl
sow
collect
first
prevaccin
day
farrow
measur
neutral
antibodi
titer
pedv
also
milk
sampl
collect
day
farrow
day
farrow
collect
serum
milk
sow
store
analysi
newborn
piglet
vaccin
group
n
control
group
n
fed
milk
includ
colostrum
deriv
vaccin
unvaccin
sow
experiment
period
addit
feed
artifici
milk
piglet
carri
piglet
oral
administ
viru
strain
day
farrow
clinic
sign
piglet
sow
monitor
day
post
challeng
clinic
sign
record
follow
score
normal
stool
score
loos
stool
score
diarrhea
score
wateri
diarrhea
score
death
viru
neutral
antibodi
test
serum
milk
carri
accord
previou
report
briefli
viru
neutral
test
perform
plate
serum
twofold
serial
dilut
triplic
per
dilut
hundr
dilut
serum
mix
equal
volum
viru
supernat
contain
ml
incub
min
mixtur
inocul
confluent
vero
cell
cultur
grown
well
incub
min
adsorpt
inoculum
remov
monolay
wash
twice
postinocul
medium
five
hundr
postinocul
medium
ad
well
incub
strain
complet
adapt
vero
cell
show
appar
cpe
neutral
antibodi
titer
determin
post
inocul
collect
milk
centrifug
min
supernat
subject
neutral
test
procedur
serum
viru
neutral
antibodi
titer
express
reciproc
highest
dilut
serum
capabl
prevent
viral
replic
efficaci
ped
live
vaccin
vaccin
nonvaccin
farm
evalu
compar
mortal
rate
suckl
piglet
onset
ped
three
farrowtofinish
farm
monitor
studi
farm
experienc
outbreak
ped
first
time
april
situat
measur
farm
list
summar
tabl
farm
b
live
vaccin
transmiss
gastroenter
tge
ped
combin
vaccin
nisseiken
co
ltd
administ
twice
pregnant
sow
accord
manufactur
instruct
pregnant
sow
vaccin
farm
c
control
oral
exposur
pedv
contamin
feedback
pregnant
sow
perform
farm
c
onset
ped
outbreak
mortal
rate
suckl
piglet
calcul
number
dead
piglet
per
piglet
born
everi
week
clinic
score
neutral
titer
mortal
rate
suckl
piglet
field
farm
analyz
repeat
analysi
varianc
anova
repeat
measur
anova
show
signific
effect
oneway
anova
pairwis
test
use
tukey
adjust
perform
time
point
pedv
isol
obtain
field
sampl
isol
viru
design
exhibit
distinct
cpe
character
cell
fusion
syncytium
format
passag
isol
serial
passag
vero
cell
total
passag
isol
viru
titer
cpe
observ
within
h
post
inocul
propag
process
fig
phylogenet
analysi
base
spike
gene
sequenc
pedv
strain
show
distribut
major
branch
indel
nonindel
strain
constitut
first
branch
second
branch
contain
indel
strain
strain
confirm
us
prototypelik
nonindel
genogroup
sublineag
fig
pedv
spike
protein
play
import
role
interact
cellular
receptor
viru
entri
growth
adapt
vitro
induct
neutral
antibodi
alter
pathogen
vivo
shown
fig
compar
amino
acid
sequenc
vaccin
strain
newli
emerg
strain
previou
studi
pedv
spike
protein
identifi
neutral
coe
region
aa
epitop
aa
aa
aa
differ
epitop
genogroup
virus
howev
two
amino
acid
differ
found
compar
genogroup
virus
strain
four
amino
acid
differ
genogroup
virus
one
amino
acid
differ
strain
spike
protein
also
known
type
glycoprotein
vaccin
strain
contain
potenti
nlink
glycosyl
site
predict
nlink
glycosyl
site
similar
among
genogroup
virus
howev
three
differ
nlink
glycosyl
site
vaccin
strain
us
prototypelik
strain
posit
studi
piglet
deriv
vaccin
nonvaccin
sow
ped
live
vaccin
challeng
strain
piglet
observ
clinic
sign
challeng
strain
data
shown
challeng
piglet
deriv
vaccin
nonvaccin
sow
show
wateri
diarrhea
day
postchalleng
fig
piglet
control
group
show
mark
reduct
surviv
rate
day
postchalleng
die
day
contrast
clinic
symptom
reliev
reach
peak
day
piglet
suckl
vaccin
sow
clinic
score
vaccin
group
significantli
lower
control
group
day
surviv
rate
day
control
group
vaccin
group
fig
vaccin
sow
show
anorexia
transient
wherea
fece
normal
experiment
period
nonvaccin
sow
show
anorexia
diarrhea
day
challeng
later
milk
secret
nonvaccin
sow
reduc
milk
could
collect
human
hand
day
postchalleng
later
therefor
piglet
deriv
nonvaccin
sow
observ
drink
lot
water
instead
take
less
milk
howev
undigest
milk
fill
stomach
piglet
die
experiment
period
neutral
antibodi
titer
serum
two
vaccin
sow
time
challeng
respect
tabl
increas
day
postchalleng
neutral
antibodi
titer
colostrum
valu
detect
limit
day
challeng
increas
sow
day
postchalleng
nonvaccin
sow
remain
antibodyneg
throughout
test
period
farm
record
mortal
rate
piglet
almost
week
onset
ped
irrespect
presenc
absenc
vaccin
pregnant
sow
fig
detail
inform
number
dead
piglet
shown
addit
file
tabl
mortal
rate
piglet
born
week
onset
ped
reduc
farm
sow
inocul
due
limit
vaccin
suppli
compar
farm
c
sow
vaccin
treat
feedback
death
record
piglet
born
week
onset
ped
sow
vaccin
twice
direct
farm
similarli
mortal
rate
piglet
reduc
week
week
onset
ped
farm
b
sow
treat
vaccin
without
feedback
compar
farm
c
sow
treat
feedback
studi
isol
newli
genogroup
viru
evalu
efficaci
convent
live
vaccin
base
genogroup
viru
vaccin
sow
show
pedspecif
antibodi
respons
neutral
antibodi
secret
colostrum
vaccin
sow
also
show
quick
antibodi
respons
challeng
quick
antibodi
respons
suggest
possibl
booster
effect
infect
sow
viru
shed
piglet
outcom
contribut
reduc
clinic
sign
mortal
rate
piglet
deriv
vaccin
sow
live
vaccin
furthermor
mortal
rate
onset
ped
reduc
vaccin
farm
compar
nonvaccin
farm
result
confirm
ped
live
vaccin
allevi
damag
due
genogroup
field
strain
experiment
condit
also
field
farm
also
suggest
sow
inocul
live
vaccin
prevent
progress
ped
sever
condit
differ
amino
acid
sequenc
nlink
glycosyl
site
found
studi
may
impact
antigen
vaccin
strain
genogroup
strain
necessari
carri
futur
research
elucid
neutral
crossreact
genogroup
virus
ped
monoval
polyval
ped
tge
live
vaccin
use
prevent
ped
japan
sinc
late
vaccin
intramuscularli
inject
twice
interv
week
pregnant
sow
gestat
period
vaccin
sow
secret
milk
contain
neutral
antibodi
pedv
farrow
secret
mani
neutral
antibodi
milk
vaccin
sow
prefer
second
vaccin
better
close
possibl
farrow
date
defin
week
farrow
accord
manufactur
instruct
neutral
antibodi
taken
piglet
gastrointestin
tract
neutral
oral
infect
pedv
block
viral
entri
mucos
epitheli
cell
reliev
ped
symptom
immun
mechan
ped
vaccin
piglet
call
lactogen
immun
work
base
differ
action
mechan
immun
piglet
matern
antibodi
colostrum
futur
studi
examin
whether
amount
viru
decreas
piglet
lactogen
immun
neutral
antibodi
consid
need
continu
suppli
gastrointestin
tract
piglet
prevent
onset
ped
milk
piglet
infect
pedv
becom
sever
unabl
take
suffici
milk
suckl
period
reason
anoth
problem
sow
low
neutral
antibodi
titer
expos
larg
amount
viru
develop
system
symptom
associ
reduc
milk
secret
limit
full
effect
vaccin
consid
mechan
ped
vaccin
suffici
increas
level
immun
sow
infect
pedv
one
import
factor
prevent
ped
pregnant
sow
acclim
use
fece
intestin
content
piglet
ped
may
induc
mucos
immun
pedv
feedback
expect
induc
highlevel
immun
booster
effect
combin
vaccin
howev
carri
risk
includ
tremend
increas
viral
load
farm
introduct
pathogen
porcin
reproduct
respiratori
syndrom
viru
porcin
circoviru
type
rotaviru
porcin
parvoviru
porcin
enteroviru
salmonella
spp
lawsonia
intracellulari
escherichia
coli
erysipelothrix
rhusiopathia
etc
via
infect
materi
pedv
includ
infect
materi
store
long
time
gener
homeus
freezer
use
suffici
viru
level
ensur
ped
rebreak
challeng
control
feedback
provid
stabl
result
complet
japanes
govern
publish
ped
prevent
manual
guid
farmer
perform
feedback
unless
veterinarian
applic
govern
agenc
involv
two
vaccin
base
genogroup
viru
alreadi
avail
us
howev
efficaci
limit
crawford
et
al
report
potenc
vaccin
develop
iowa
sow
result
studi
averag
litter
mortal
control
group
averag
mortal
vaccin
group
even
vaccin
base
genogroup
viru
use
hard
confer
protect
immun
pedv
paper
discuss
effect
ped
live
vaccin
current
avail
japan
examin
laboratori
test
field
trial
although
ped
live
vaccin
could
protect
sow
viral
infect
provid
effect
protect
field
strain
new
genet
group
damag
ped
report
even
vaccin
farm
japan
ideal
vaccin
overcom
problem
would
provid
sow
mucos
immun
piglet
potent
lactogen
immun
protect
viral
infect
research
would
warrant
develop
ideal
vaccin
close
understand
pathogen
mechan
ped
examin
immun
method
instead
intramuscular
inject
develop
effect
antigen
induc
mucos
immun
respons
